PRESENCE AND SEVERITY OF DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA

Size: px
Start display at page:

Download "PRESENCE AND SEVERITY OF DEPRESSIVE SYMPTOMS IN SCHIZOPHRENIA"

Transcription

1 ORIGIAL ARTICLE PRESECE AD SEVERITY OF DEPRESSIVE SYMPTOMS I SCHIZOPHREIA Zahid azar, Rubina Shaheen, Javaid Akhtar, Muneer Ahmed, Muhammad Irfan, Rahat Sajjad, Saeed Farooq Department of Psychiatry, Lady Reading Hospital Peshawar, Gomal Medical College, DI Khan ICMS Peshawar, Department of Psychology, University of Peshawar - Pakistan ABSTRACT Objectives: The present study aims to assess the presence and severity of depressive symptoms in persons suffering from schizophrenia as compared to normal healthy controls. Material and Methods: This case control comparative study was carried out at the Department of Psychiatry, Postgraduate Medical Institute, Lady Reading Hospital Peshawar from January to December. One twenty subjects were included in the study by non probability convenient sampling. Group (the study group) included sixty patients suffering from schizophrenia between the ages of - and Group (the control group) included sixty normal subjects without any major psychiatric disorder proportionally matched for age and gender. Those suffering from schizoaffective illness, major depression and organic brain damage were excluded. Hamilton Depression Rating Scale (HDRS), a item scale was used to assess the presence and severity of depressive symptoms. Results: The spectrum of depressive symptoms was broad in the schizophrenic sample. The difference in two groups was observed specially in depressed mood i.e., patients in the study vs. subjects in the control group with a p value of. and in psychomotor retardation i.e., patients in the study vs. subjects in the control group, again with a p value of.. Conclusion: The results of this study suggest that depressive symptoms are a part and parcel of schizophrenia and every patient suffering from schizophrenia should be assessed in detail for the presence and severity of depressive symptoms. Key Words: Schizophrenia, Depressive symptoms, Hamilton Depression Rating Scale (HDRS). ITRODUCTIO the illness; whether positive psychotic symptoms are acute or not prominent, they flare up the Ever since Kraeplin it was considered that deficit in psychosocial functioning and commonly depressive symptoms occur commonly in precede attempted and/ or completed suicide. schizophrenia, both in the acute and the chronic stage. T h e a s s e s s m e n t a n d t r e a t m e n t o f depressive symptoms in schizophrenia remains Mayer Gross felt the gloom occurring as a clinically challenging as depressive symptoms result of the Psychological reaction to acute seem to be a part and parcel of schizophrenia even psychotic episode and Bleuler considered in a specifically designed study not to be having depression to be one of the essential features of schizoaffective disorder patients. schizophrenia. As there is increasing evidence, that the These clinical observations have been depressive symptoms in schizophrenia can be confirmed recently by using standardized methods - treated effectively by recent advances in of assessment. Depressive symptoms in psychopharmacology and this in turn can reduce schizophrenia are important because they the morbidity and mortality in schizophrenic contribute significantly to the suffering caused by

2 SOCIODEMOGRAPHIC CHARACTERISTICS OF MID TO LATE LIFE, PATIETS WITH SCHIZOPHREIA AD ORMAL COMPARISO SUBJECT Schizophrenia Group ormal compassion group Diagnostic effect Dependent variable Men (n= ) Women (n=) Men (n=) Women (n=) for df p Effect size X Continuous variable Mean SD Mean SD Mean SD Mean SD F df p d Age (years) Education years Mini mental State score Categorical Variables Family history of mood disorder on Caucasian Independent living situation Currently married Ever married Had previous psychiatric hospitalization Family history of Schizophrenia.. population, present study was therefore designed years were included, while normal subjects, as to assess the presence and severity of depressive symptoms in the patients suffering from schizophrenia as compared to the normal subjects. MATERIAL AD METHODS Table the medical attendant of the patients, were included in Group. All those suffering from schizoaffective disorder, major depressive disorder and gross brain damage were excluded from the study. This comparative study was carried out in Details were recorded on semi structured the department of Psychiatry, Postgraduate Medical questionnaire prepared in accordance with the Institute, Lady Reading Hospital, Peshawar from objectives of the study including the record of any January to December. One twenty subjects, previous psychiatric hospitalization, family history sixty each in two groups were included in the of mood disorder or schizophrenia, current living study using non probability convenient sampling. situation and details of availability of system of Group (the study group) included sixty patients support. suffering from schizophrenia and Group (the control group) included sixty normal subjects Along with administering the semi w i t h o u t a n y m a j o r p s y c h i a t r i c d i s o r d e r structured clinical interview, sociodemographic proportionally matched for age and gender. information and information regarding depressive symptoms by using Hamilton Depression Rating In Group, all those persons fulfilling the Scale was gathered. Diagnostic and Statistical Manual of Mental th Disorders, Edition, Text Revised (DSM-IV TR) Initially the score of the first items on criteria for schizophrenia, between the ages of - the Hamilton Depression Rating Scale was considered but since the first items of the scale X af... P n

3 RATES OF MODERATE/ SEVERE DEPRESSIVE SYMPTOMS OR CLIICAL SIGIFICAT DEPRESSIO I MID TO LATE LIFE PATIETS WITH SCHIZOPHREIA AD ORMAL COMPARISO SUBJECTS Schizophrenia Group ormal compassion group Dependent variable Men (n= ) Women (n=) Men (n=) Women (n=) Diagnosis effect Depression variable Based on Hamilton Depression Rating Scale Score > on first items. Depressed Mood. Feelings of Guilt. Suicidal ideation. Early Insomnia. Middle Insomnia. Late Insomnia. Work and activities. Retardation. Agitation.Anxiety-Psychic.Somatic Anxiety. Gastrointestinal Somatic Symptoms.General Somatic Symptoms.Genital Symptoms.Hypochondriasis. Loss of Weight. Loss of Insight Additional items.diurnal Variation. Depersonalization and Derealization. Paranoid Symptoms.Obsessive Compulsive Symptoms X have been criticized for its bias towards somatic symptoms, which may increase with normal aging, Table (df) a total score was calculated including the last four items i.e. - which are Diurnal variation, P Effect Size

4 SEVERITY OF DEPRESSIO AMOG MID TO LATE LIFE PATIETS WITH SCHIZOPHREIA AD ORMAL COMPARISO SUBJECT Severity according to sum of scores on First items Hamilton Depression Rating Scale one to Mild (Sum < ) Mild to Moderate (Sum=-) Moderate to Severe (sum > ) Schizophrenia Group Men (n=) Women (n=) Table ormal Comparison Group Men (n=) Women (n=) Depersonalization and Derealization, Paranoid significant in depersonalization and derealization Symptoms and Obsessive Compulsive Symptoms. i.e., patients in the study vs. subject in the control group with a p value of.. Over all, The data obtained was analyzed both each of the depressive symptoms was more qualitatively and quantitatively by using Statistical frequent in schizophrenic patients than in the Package for Social Sciences (SPSS ) with results normal subjects. (table ) showing mean, standard deviation, degree of freedom and p value, which was considered The percentage of individuals with scores significant below.. of or more, between and and or less on RESULTS the first items of the Hamilton depression scale are given in table. These cut off points were The two groups each with respondents selected because they have previously been shown were well matched on most demographic features. to represent moderate to severe depression on a Schizophrenic patients were more likely to have score of or more, mild to moderate depression had previous psychiatric hospitalization i.e., as on a score of to and none to mild severity on compared to none in males and as compared to a score of or less. (table-) none in females had previous psychiatric hospitalization. They were likely to be currently having lower mean scores on the mini-mental state DISCUSSIO To our knowledge, present study is the than normal group i.e.,. as compared to. first of its kind looking at the break down of in males and. as compared to in females. various depressive symptoms on HDRS, although o diagnosis by gender interaction effects was depression in general has been studied extensively significant. Table shows the demographic break in Schizophrenia and has been found to be up and details of semi structured clinical interview common. So the comparison of these symptoms is of both the groups. (table ) not possible with other studies that just show depression as a whole and not the variety of A list for each of the groups with symptoms of depression. percentage of depressive symptoms (score of or more) rated on each of the first items of the Recent advances in psychopharmacology Hamilton Depression Rating Scale is given in table and other treatment approaches elevate the. The difference in two groups was observed importance of establishing the diagnosis in the specially in depressed mood i.e., patients in the initial part of illness. The final treatment goal in study vs. subjects in the control group with a p schizophrenia is to significantly reduce the value of. and in psychomotor retardation mortality and morbidity and if the associated i.e., patients in the study vs. subjects in the depressive symptoms are diagnosed earlier, they control group, again with a p value of.. can well be treated and thus will help in reducing Four additional items that may reflect some of the the mortality and morbidity over all. more severe psychological symptoms were also During acute phase of the illness adequate tabulated. The difference in two groups was most anti-psychotic medication, good psycho-social

5 support and if indicated hospitalization will schizophrenia. successfully ameliorate both depressive as well as positive symptoms. There is compelling evidence to try antidepressant, when patient has persistent depressive symptoms and is not in a phase of acute - illness. As far as electroconvulsive therapy (ECT) is concerned, no significant improvement in depressive symptoms has been reported in patients suffering from schizophrenia. Rehabilitation, social support and meaningful social role can have favorable effects. Cognitive Behavioral Therapy has been shown to have positive effect on depressive symptoms in schizophrenia. F o r b o t h m e n a n d w o m e n w i t h schizophrenia, depressive symptoms were frequent and did not appear to be a by product of age, neuroleptics, family history, negative symptoms or,. movement disorder The spectrum of depressive symptoms seen in schizophrenic patients was wideranging. The differences in depressive symptoms between the schizophrenics and normal groups were observed in terms of the severity of feeling of hopelessness, helplessness (depressed mood) and psychomotor retardation. Other depressive symptoms were also frequent in schizophrenia although they did not meet the criteria for major depressive disorder. One fifth of the female schizophrenics had or more on score on items Hamilton depression rating scale which shows moderate to severe depression. When lesser degrees of depression were also taken into account, the over whelming majority of both men and women with schizophrenia had at least subsyndrome symptoms of depression. The clinical importance of this finding is underscored by several studies that describe sub syndrome depressive symptoms in non psychotic patients being associated with considerable social dysfunction and disability, suicidal attempts and - risk of later major depressive disorder. It is also worth mentioning that rate of mild depressive symptoms in our normal comparison group is well in line with the rate of,. sub syndrome depression There are several reasons why depressive symptoms may be associated with schizophrenia:. As an adverse effect of antipsychotic medications. Although these can occur in patients not on antipsychotics but a kinetic side effect of medication may be wrongly attributed as depressive retardation.. These may be a response to the recovery of insight into the illness and the problems to be faced. Again, this might take place at times, but provide an influential general justification.. D e p r e s s i o n b e i n g a n i n t e g r a l p a r t o f In a study of patients after the acute onset of schizophrenia, the investigators have found depression to be most common in the acute phase, decreasing during the following three months. They concluded that depression is a symptom of schizophrenia although it may be recognized only after more striking psychotic symptoms have improved, of people who have suffered a depressive disorder at any time during the illness,, and out of these percent will be suicidal. COCLUSIO The results of this study suggest that depressive symptoms are a part and parcel of schizophrenia and every patient suffering from schizophrenia should be assessed in detail for the presence and severity of depressive symptoms. However further studies with a larger sample size will be required to find out the most common depressive symptoms in schizophrenia and the approach to overcome them. REFERECE. Levinson DF, Umpathy C, Mushtaq M. Treatment of Schizoaffective disorder and schizophrenia with mood symptom. Am J Psychiatry ; ():-.. Mulholland C, Cooper S. The symptoms of d e p r e s s i o n i n s c h i z o p h r e n i a a n d i t s management. Adv Psych Treat ; : -.. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Martindale B, et al. Psychological treatment in schizophrenia II: Meta-analysis of randomized controlled trials of social skills training and cognitive remediation. Psychol Med ; : -.. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of post-psychotic depression: a controlled trial. Arch Gen Psychiatry ; :-.. Geddes J, Free-mantle, Harrisan P, Bebbingtan P. Atypical anti psychotic in the treatment of schizophrenia: Systematic review and meta-regression analysis. Br Med J ; : -.. Siris SG, Bermanzohn PC, Meson SE, Showall MA. Maintenance Imipramine therapy for secondary depression in schizophrenia: A Controlled Trial. Arch Gen Psychiatry ; : -.. Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ. Efficacy and tolerability of

6 ziprasidone Versus Risperidone in patients. Sensky T, Turkington D, Kingdon D, Scott JL, with acute exacerbation of schizophrenia or Scott J, Siddle R, et al. A Randomized schizoaffective disorder. An week double Controlled Trial of Cognitive-Behavioral blind Multi centre trial. J Clin Psychiatry T h e r a p y f o r P e r s i s t e n t S y m p t o m s i n ; : -. Schizophrenia Resistant to Medication. Arch. Glick ID, Marder SR. Long term maintenance Gen Psychiatry ;: -. with Quetiapine versus haloperidol deaconate. Emsley R, Turner HJ, Schronen J, Botha K, i n p a t i e n t s w i t h s c h i z o p h r e n i a o r Smit R, Oosthuizen PP. A single Blind schizoaffective disorder: J Clin Psychiatry Randomized trial comparing Quetiapine and ; (): -. Haloperidol in the treatment of tardive. dyskinesia. J Clin Psychiatry ; : - American Psychiatric Association. Diagnostic. and statistical manual of mental disorders, th ed. Washington DC: APA;.. Hahn CG, Gyulai L, Baidassono CF, Lenox RH. The current understanding of Lamotrigine. Hamilton MA, Rating Scale for depression. J as a mood stabilizer. J Clin Psychiatry ; eurol eurosurg Psychiatry ; : -. : -.. Siris SG. Depression in Schizophrenia:. Kessler RC, Berglund P, Berges G, ock M, Perspective in the Era of Atypical Wang PS. Trends in suicide ideation, Plans, Antipsychotic Agents. Am J Psychiatry ; Gestures and attempts in the United States :-. - to -. JAMA ; :. P l a s k y P. A n t i d e p r e s s a n t u s a g e i n -. schizophrenia. Schizophr Bull ; :-. Heila H, Haukka J, Suvisaari J, Lönnqvist J.. Mortality Among patients With Schizophrenia. Evins AE, Goff DC. Adjunctive antidepressant and reduced psychiatric hospital care. Psychol drug therapies in the treatment of negative Med ; : -. symptoms of schizophrenia. Drug Therapy ; :-. Address for Correspondence: Dr. Zahid azar Assistant Professor Department of Psychiatry, Postgraduate Medical Institute, Lady Reading Hospital, Peshawar.

Multistate Outcome Analysis of Treatment MOAT

Multistate Outcome Analysis of Treatment MOAT Multistate Outcome Analysis of Treatment MOAT Charles L. Bowden, M.D. Presented with Fond Memories of an Outstanding Statistician and Investigative Scientist Andy Leon Design contributors to low generalizability

More information

EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION

EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 7 (56) No. 1-2014 EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION

More information

Treatment of Schizophrenia

Treatment of Schizophrenia Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,

More information

Recent Advances in the Antipsychotic Treatment of People with schizophrenia. Robert W. Buchanan, M.D.

Recent Advances in the Antipsychotic Treatment of People with schizophrenia. Robert W. Buchanan, M.D. Recent Advances in the Antipsychotic Treatment of People with schizophrenia Robert W. Buchanan, M.D. Antipsychotic medications are the primary class of drugs used in the pharmacological treatment of schizophrenia.

More information

Is Lurasidone more safe and effective in the treatment ofschizoaffective disorder and schizophrenia than other commonanti-psychotic medications?

Is Lurasidone more safe and effective in the treatment ofschizoaffective disorder and schizophrenia than other commonanti-psychotic medications? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Is Lurasidone more safe and effective

More information

GOALS FOR THE PSCYHIATRY CLERKSHIP

GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS FOR THE PSCYHIATRY CLERKSHIP GOALS - The aim of the core psychiatry clerkship is to expose students to patients with mental illness and to prepare them to provide psychiatric care at a basic level.

More information

Is Aristada (Aripiprazole Lauroxil) a Safe and Effective Treatment For Schizophrenia In Adult Patients?

Is Aristada (Aripiprazole Lauroxil) a Safe and Effective Treatment For Schizophrenia In Adult Patients? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Aristada (Aripiprazole Lauroxil)

More information

ADVERSE SIDE EFFECTS OF LITHIUM AND FASTING (RAMADAN)

ADVERSE SIDE EFFECTS OF LITHIUM AND FASTING (RAMADAN) ORIGINAL ARTICLE ADVERSE SIDE EFFECTS OF LITHIUM AND FASTING (RAMADAN) Zahid Nazar, Javaid Akhtar, Saeed Farooq, Muhammad Irfan, Rubina Shaheen, Muneer Ahmed, Naila Riaz Awan, Zia Ahmad, Fazal e Subhan,

More information

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1%

Chapter 12 1/29/2018. Schizophrenia and Schizophrenia Spectrum Disorders. Epidemiology. Comorbidity. Lifetime prevalence of schizophrenia is 1% Chapter 12 Schizophrenia and Schizophrenia Spectrum Disorders Epidemiology Lifetime prevalence of schizophrenia is 1% No difference related to 2 Comorbidity Substance abuse disorders Anxiety, depression,

More information

PROVIDED IN RESPONSE TO YOUR UNSOLICITED REQUEST FOR INFORMATION

PROVIDED IN RESPONSE TO YOUR UNSOLICITED REQUEST FOR INFORMATION KINECT 2 NCT01733121 Baseline Week 2 Week 4 Week 6 Valbenazine 25-75 mg Valbenazine 40 mg KINECT 3 NCT02274558 Valbenazine 80 mg a KINECT 2 and KINECT 3 were 6-week, double-blind placebo-controlled trials

More information

June 2015 MRC2.CORP.D.00030

June 2015 MRC2.CORP.D.00030 This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. June 2015 MRC2.CORP.D.00030 advice or professional

More information

Initial Prodrome Description in Recent Onset Schizophrenia

Initial Prodrome Description in Recent Onset Schizophrenia Amr El-Shribiny et al. Initial Prodrome Description in Recent Onset Schizophrenia Amr M M El-Shribiny, Salwa M. Rabie, Hanaa S. Soliman, Refaat Mahfouz Department of Neurology and Psychiatry, El-Minia

More information

Predictors of Suicide Attempt Among those with Depression in an Indian Sample: A Brief Report

Predictors of Suicide Attempt Among those with Depression in an Indian Sample: A Brief Report ISPUB.COM The Internet Journal of Mental Health Volume 4 Number 2 Predictors of Suicide Attempt Among those with Depression in an Indian Sample: A Brief Report R Chakraborty, A Chatterjee Citation R Chakraborty,

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lam RW, Levitt AJ, Levitan RD, et al. Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized

More information

Co-relation of Insight,stigma& treatment adherence in Psychiatry patients

Co-relation of Insight,stigma& treatment adherence in Psychiatry patients Original research Article Co-relation of Insight,stigma& treatment adherence in Psychiatry patients 1 Dr Pawan Vilas Khot, 2 Dr Rajkiran Arjun Salunkhe, 3 Dr Maithili Umate, 4 Dr Vinayak P Kale 1 Assistant

More information

Screening Tests for Depression

Screening Tests for Depression Page 1 of 8 Medscape Reference Reference News Reference Education MEDLINE Screening Tests for Depression Author: David Bienenfeld, MD; Chief Editor: David Bienenfeld, MD more... Updated: Nov 12, 2012 Overview

More information

MENTAL HEALTH DISEASE CLASSIFICATIONS

MENTAL HEALTH DISEASE CLASSIFICATIONS MENTAL HEALTH DISEASE CLASSIFICATIONS DIAGNOSIS OF MENTAL DISORDERS DSM-IV-TR Published by APA ( 2000 ) Multiaxial system 5 categories called axes Facilitate holistic assessment for care Is a great resource

More information

Scoring/ Administration instructions ( 17 sets of question criteria) Buy full version here - for $7.00

Scoring/ Administration instructions ( 17 sets of question criteria) Buy full version here - for $7.00 This is a Sample version of the Hamilton Depression. Scale (HAM-D) The full version of Hamilton Depression Scale comes without sample watermark.. The full complete 18 page version includes HAM-D Clinical

More information

Suicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative

Suicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative Suicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative Robert I. Simon, M.D.* Suicide risk is increased in patients with Major Depressive Disorder with Melancholic

More information

THERAPEUTIC AND EVOLUTIVE ASPECTS IN SCHIZOPHRENIA

THERAPEUTIC AND EVOLUTIVE ASPECTS IN SCHIZOPHRENIA UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA THERAPEUTIC AND EVOLUTIVE ASPECTS IN SCHIZOPHRENIA ABSTRACT Ph.D. Coordinator Professor Dragoș MARINESCU PhD Student: Mihai MUTICĂ Craiova 2016 TABLE OF CONTENTS

More information

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

Office Practice Coding Assistance - Overview

Office Practice Coding Assistance - Overview Office Practice Coding Assistance - Overview Three office coding assistance resources are provided in the STABLE Resource Toolkit. Depression & Bipolar Coding Reference: n Provides ICD9CM and DSM-IV-TR

More information

BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0)

BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) General information The Bipolar Affective Disorder Dimension Scale (BADDS) has been developed in order to address

More information

Mending the Mind: treatment of the severely mentally ill

Mending the Mind: treatment of the severely mentally ill Mending the Mind: treatment of the severely mentally ill First, the bad news Mental Illness Prevalence: putting things in perspective --More than 54 million Americans have a mental disorder in any given

More information

A STUDY OF PREVALENCE OF MAJOR DEPRESSIVE DISORDER IN PATIENTS PRIMARILY HAVE HEADACHE AS A SYMPTOM

A STUDY OF PREVALENCE OF MAJOR DEPRESSIVE DISORDER IN PATIENTS PRIMARILY HAVE HEADACHE AS A SYMPTOM 3 Original article A STUDY OF PREVALENCE OF MAJOR DEPRESSIVE DISORDER IN PATIENTS PRIMARILY HAVE HEADACHE AS A SYMPTOM Dr. Vaishal N. Vora, M.D. (Psychiatry), D.P.M, Consultant Psychiatrist, Chairman,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Daly EJ, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized

More information

Adult Depression - Clinical Practice Guideline

Adult Depression - Clinical Practice Guideline 1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)

More information

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

9/24/2012. Amer M Burhan, MBChB, FRCP(C) Depression and Dementia Amer M Burhan MBChB, FRCPC Head of CAMH Memory Clinic, Toronto Geriatric Neuropsychiatrist Assistant Prof Psychiatry at U of T Objectives Discuss the prevalence and impact of depression

More information

Psychosis, Mood, and Personality: A Clinical Perspective

Psychosis, Mood, and Personality: A Clinical Perspective Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco

More information

Review: Psychosocial assessment and theories of development from N141 and Psych 101

Review: Psychosocial assessment and theories of development from N141 and Psych 101 Unit III Theory and Practice of Psychiatric Nursing REQUIRED READINGS AND ACTIVITIES Related Activities Assignments Review: Psychosocial assessment and theories of development from N141 and Psych 101 Anxiety,

More information

Role of Clozapine in Treatment-Resistant Schizophrenia

Role of Clozapine in Treatment-Resistant Schizophrenia Disease Management and Treatment Strategies Elkis H, Meltzer HY (eds): Therapy-Resistant Schizophrenia. Adv Biol Psychiatry. Basel, Karger, 2010, vol 26, pp 114 128 Role of Clozapine in Treatment-Resistant

More information

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.

More information

University of Groningen. Neurological soft signs in schizophrenia and mood disorders Boks, Marco Paul Maria

University of Groningen. Neurological soft signs in schizophrenia and mood disorders Boks, Marco Paul Maria University of Groningen Neurological soft signs in schizophrenia and mood disorders Boks, Marco Paul Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Affective Disorders.

Affective Disorders. Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders

More information

RUNNING HEAD: Efficacy, Long Acting Injectable Antipsychotics and Schizophrenia 1

RUNNING HEAD: Efficacy, Long Acting Injectable Antipsychotics and Schizophrenia 1 RUNNING HEAD: Efficacy, Long Acting Injectable Antipsychotics and Schizophrenia 1 Efficacy of Long Acting Injectable Antipsychotics in Early Onset Schizophrenia Linda Pietras RN-BC Mercyhurst University

More information

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.

Guilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant. 1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number

More information

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related.

6/22/2012. Co-morbidity - when two or more conditions occur together. The two conditions may or may not be causally related. Autism Spectrum Disorders and Co-existing Mental Health Issues By Dr. Karen Berkman Objective To present an overview of common psychiatric conditions that occur in persons with autism spectrum disorders

More information

Presented at the American Psychiatric Association Annual Meeting May 20 24, 2017 San Diego, CA.

Presented at the American Psychiatric Association Annual Meeting May 20 24, 2017 San Diego, CA. Original Presentations Key Words: amines, antipsychotic agents, double-blind method, mood disorders, psychopharmacology, psychotic disorders, schizophrenia, tardive dyskinesia, valbenazine Efficacy of

More information

Manual of Clinical Psychopharmacology

Manual of Clinical Psychopharmacology Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School

More information

** * *Correspondence ***

** * *Correspondence   *** Journal of Clinical Psychology Vol. 2, No. 2 (6), Summer 2010 Pages:11-26 1389 (6 ) 2 11-26 : - The Effectiveness of Anxiety-Reduction Cognitive-Behavioral Techniques in Treating Paranoid Ideation and

More information

Teaching Job Interview Skills to Psychiatrically Disabled People Using Virtual Interviewers

Teaching Job Interview Skills to Psychiatrically Disabled People Using Virtual Interviewers Teaching Job Interview Skills to Psychiatrically Disabled People Using Virtual Interviewers Summary Patients with psychiatric illnesses such as schizophrenia, posttraumatic stress disorder (PTSD), mood

More information

Depression in the Eldery Handout Package

Depression in the Eldery Handout Package Depression in the Eldery Handout Package Depression in the Elderly 1 Learning Objectives Upon completion of this module, you should be able to: 1. State the prevalence and describe the consequences of

More information

Understanding Psychiatry & Mental Illness

Understanding Psychiatry & Mental Illness Understanding Psychiatry & Steve Ellen Mental Illness MB, BS. M.Med. MD. FRANZCP Head, Consultation, Liaison & Emergency Psychiatry, Alfred Health. Associate Professor, Monash Alfred Psychiatry Research

More information

SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2

SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Psychiatrická klinika LFUK a UNB, Bratislava SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Author: MUDr. Ľubomíra Izáková, PhD. Supervisor: doc. MUDr. Ján Pečeňák, CSc. Podporené grantom

More information

DEPRESSION AFTER STROKE

DEPRESSION AFTER STROKE DEPRESSION AFTER STROKE Research study results and practical suggestions Julie Kidd 1 November 2018 Outline Definition Diagnosis Associations Prevention Treatment Outcomes From a person with stroke Emphasises

More information

Relationship between Positive and Negative Symptoms of Schizophrenia and Psychotic Depression with Risk of Suicide

Relationship between Positive and Negative Symptoms of Schizophrenia and Psychotic Depression with Risk of Suicide Original Article Relationship between Positive and Negative Symptoms of Schizophrenia and Psychotic Depression with Risk of Suicide Ebrahim Abdollahian, MD *, Morterza Modares Gharavi, PhD * Atefeh Soltanifar,

More information

Results. NeuRA Treatments for dual diagnosis August 2016

Results. NeuRA Treatments for dual diagnosis August 2016 Introduction Many treatments have been targeted to improving symptom severity for people suffering schizophrenia in combination with substance use problems. Studies of dual diagnosis often investigate

More information

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY Indian Journal of Psychiatry, January 29(1), pp 49-56 ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY A total of 90 patients

More information

Treatment of Children and Adolescents with Schizophrenia

Treatment of Children and Adolescents with Schizophrenia Treatment of Children and Adolescents with Schizophrenia The evidence base pertaining to the pharmacotherapy of schizophrenia in children and adolescents (C&A) is tiny compared to what is available for

More information

Schizophrenia. Class Objectives. Can someone be psychotic without having schizophrenia? 12/7/2011. Other psychotic disorders and causes

Schizophrenia. Class Objectives. Can someone be psychotic without having schizophrenia? 12/7/2011. Other psychotic disorders and causes Schizophrenia Other psychotic disorders and causes Class Objectives What are Delusional Disorders? What causes Schizophrenia? How can Schizophrenia be treated? Can someone be psychotic without having schizophrenia?

More information

EARLY ONSET SCHIZOPHRENIA

EARLY ONSET SCHIZOPHRENIA Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington

More information

COPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS

COPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS Indian Journal of Psychiatry, 2002,44(1 ),9-13 COPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS R.CHANDRASEKARAN, SIVAPRAKASH B.& S.R JAYESTRI ABSTRACT Families caring for a member with a chronic

More information

I received help from Bosch Health Care

I received help from Bosch Health Care John Kasckow, MD, PhD VA Pittsburgh Health Care System Western Psychiatric Institute and Clinic, UPMC VA Pittsburgh Health Care System I received help from Bosch Health Care 1 Diagnoses of Interest Early

More information

Class Update: Oral Antipsychotics

Class Update: Oral Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum Session 4022: American Psychiatric Nurses Association National Conference, Louisville, KY Andrew Penn, RN, MS, NP, CNS Psychiatric

More information

THE HAMILTON Depression Rating Scale

THE HAMILTON Depression Rating Scale Reliability and Validity of the Turkish Version of the Hamilton Depression Rating Scale A. Akdemir, M.H. Türkçapar, S.D. Örsel, N. Demirergi, I. Dag, and M.H. Özbay The aim of the study was to examine

More information

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:

More information

Psychopharmacological treatment of first episode psychosis

Psychopharmacological treatment of first episode psychosis Psychopharmacological treatment of first episode psychosis Matcheri S Keshavan MD First episode Psychosis Treatment Assistance Center (FEP-TAC), Harvard Medical School, Beth Israel Deaconess Medical Center

More information

The Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatment of Patients with Bipolar Disorder

The Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatment of Patients with Bipolar Disorder Zahedan Journal of Research in Medical Sciences Journal homepage: www.zjrms.ir The Comparison of the Effectiveness of Thiothixene and Risperidone as a Combination with Lithium for the Treatment of Patients

More information

Mental Health Series for Perinatal Prescribers. Severe postpartum syndromes

Mental Health Series for Perinatal Prescribers. Severe postpartum syndromes Mental Health Series for Perinatal Prescribers Severe postpartum syndromes 2 Maternal Filicides Acutely psychotic - 24% Depression Altruistic - 56% to relieve suffering associated with suicide 80% due

More information

Chapter 1.4. Intermittent neuroleptic treatment is a risk factor for tardive dyskinesia

Chapter 1.4. Intermittent neuroleptic treatment is a risk factor for tardive dyskinesia Intermittent neuroleptic treatment is a risk factor for tardive dyskinesia The Curaçao Extrapyramidal Syndromes Study: III. Peter N. van Harten (1,3), Hans W. Hoek (2), Glenn E. Matroos (3), Maarten Koeter

More information

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice

More information

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability

More information

Mental Health Pathway

Mental Health Pathway Mental Health Pathway Triggers for Mental Health Pathway Information for professionals Consider mainstream Mental Health Services (Green light Toolkit) Clinical Interface Protocol Clinical Assessment Information

More information

Istvan Bitter Department t of Psychiatry and Psychotherapy

Istvan Bitter Department t of Psychiatry and Psychotherapy Suicide in Schizophrenia & Affective disorders March 3, 2010 Istvan Bitter Department t of Psychiatry and Psychotherapy Map of Suicide Rates (per 100,000; most recent year available, March 2002) Adapted

More information

FAMILY AND ADOLESCENT MENTAL HEALTH: THE PEDIATRICIAN S ROLE

FAMILY AND ADOLESCENT MENTAL HEALTH: THE PEDIATRICIAN S ROLE FAMILY AND ADOLESCENT MENTAL HEALTH: THE PEDIATRICIAN S ROLE Mark Cavitt, M.D. Medical Director, Pediatric Psychiatry All Children s Hospital/Johns Hopkins Medicine OBJECTIVES Review the prevalence of

More information

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines Non-Formulary Behavioral Health Medications ADHD medications for children under The patient must have a diagnosis for which the requested medication is: o Approved based on FDA indication and limits; OR

More information

NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression)

NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression) NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression) 11 APRIL 2013 Josephine Cucchiaro, PhD Vice President Clinical Operations & Project Management Sunovion Pharmaceuticals

More information

Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers

Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers Tuesday, February 23, 2016 2pm Eastern Delbert Robinson, M.D. Professor of Psychiatry and Molecular Medicine

More information

Efficacy of modified compliance therapy for schizophrenia patients

Efficacy of modified compliance therapy for schizophrenia patients Original article Efficacy of modified compliance therapy for schizophrenia patients Victoria Omranifard 1, Mojgan Karahmadi 2, Zahra Jannesari 3, Mohammad Maracy 4 1 Associate Professor, Psychosomatic

More information

Depression in the Medically Ill

Depression in the Medically Ill Mayo School of Continuous Professional Development Psychiatry in Medical Settings February 9 th, 2017 Depression in the Medically Ill David Katzelnick, M.D. Professor of Psychiatry, Mayo Clinic College

More information

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island #CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Bipolar Depression: Putting the End Goal

More information

Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity

Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity Measure #106 (NQF 0103): Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity 2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

Alternative Thresholds for Negative and Positive Symptoms in the CATIE Trial: Implications for Negative Symptom Clinical Trials

Alternative Thresholds for Negative and Positive Symptoms in the CATIE Trial: Implications for Negative Symptom Clinical Trials Alternative Thresholds for Negative and Positive Symptoms in the CATIE Trial: Implications for Negative Symptom Clinical Trials Eduardo Dunayevich, Chao-Yin Chen, Stephen Marder and Jonathan Rabinowitz

More information

CAN I REALLY USE THERAPY FOR PATIENTS WITH PSYCHOSIS?: COGNITIVE BEHAVIORAL THERAPY FOR SCHIZOPHRENIA SPECTRUM DISORDERS

CAN I REALLY USE THERAPY FOR PATIENTS WITH PSYCHOSIS?: COGNITIVE BEHAVIORAL THERAPY FOR SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences CAN I REALLY USE THERAPY FOR PATIENTS WITH PSYCHOSIS?: COGNITIVE BEHAVIORAL THERAPY FOR SCHIZOPHRENIA SPECTRUM DISORDERS

More information

Raman Krishnan 1,*, Sharma PSVN 2. Manipal. *Corresponding Author:

Raman Krishnan 1,*, Sharma PSVN 2. Manipal. *Corresponding Author: Original Research Article A comparative study of clinical correlates of bipolar mixed state with bipolar manic and bipolar depressed state in a general hospital psychiatry setting Raman Krishnan 1,*, Sharma

More information

With Mild and More Severe Intellectual Disabilities Referred to a Dual Diagnosis Service. Abstract. Authors

With Mild and More Severe Intellectual Disabilities Referred to a Dual Diagnosis Service. Abstract. Authors brief report: Comparison of Clients With Mild and More Severe Intellectual Disabilities Referred to a Dual Diagnosis Service Abstract Authors Jonny Elserafi, 1,2 Stacy E. White, 1 Yona Lunsky 1,2 1 Dual

More information

depression and anxiety in later life clinical challenges and creative research

depression and anxiety in later life clinical challenges and creative research 2 nd Annual MARC Symposium Critical Themes in Ageing Melbourne, 10 th August 2018 depression and anxiety in later life clinical challenges and creative research Nicola T Lautenschlager, MD, FRANZCP Professor

More information

CASE 5 - Toy & Klamen CASE FILES: Psychiatry

CASE 5 - Toy & Klamen CASE FILES: Psychiatry CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The

More information

ACUTE INPATIENT TREATMENT

ACUTE INPATIENT TREATMENT I. Definition of Service: ACUTE INPATIENT TREATMENT Acute inpatient hospitalization represents the most intensive level of psychiatric care. Multidisciplinary assessments and multimodal interventions are

More information

Schizophrenia: A Lifelong Illness

Schizophrenia: A Lifelong Illness Schizophrenia: A Lifelong Illness Medical Director Brain Health Exeter, NH Objectives Appreciate the historical perspectives of schizophrenia Describe our current understanding of the etiology of schizophrenia

More information

Erotomanic type- central theme of the delusion is that another person is in love with the individual. Grandiose type- central theme of the delusion

Erotomanic type- central theme of the delusion is that another person is in love with the individual. Grandiose type- central theme of the delusion A. Presence of one or more non-bizarre delusions that persist for at least one month B. Diagnosis of Delusional Disorder is not given if person has had symptom presentation that met criterion A for Schizophrenia

More information

Active listening. drugs used to control anxiety and agitation. Antianxiety drugs

Active listening. drugs used to control anxiety and agitation. Antianxiety drugs Active listening empathic listening in which the listener echoes, restates, and clarifies. A feature of Rogers' client-centered therapy. Antianxiety drugs drugs used to control anxiety and agitation. Antidepressant

More information

Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial Amr et al. International Archives of Medicine 2013, 6:47 ORIGINAL RESEARCH Open Access Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

DSM5: How to Understand It and How to Help

DSM5: How to Understand It and How to Help DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental

More information

Schizophrenia. Can someone be psychotic without having schizophrenia? 11/30/2008. Name that Psychotic Disorder! Other psychotic disorders and causes

Schizophrenia. Can someone be psychotic without having schizophrenia? 11/30/2008. Name that Psychotic Disorder! Other psychotic disorders and causes Schizophrenia Other psychotic disorders and causes Name that Psychotic Disorder! Chris has started spending large amounts of time guarding his home. They have bugged his phone and are sending cars past

More information

Depression: Assessment and Treatment For Older Adults

Depression: Assessment and Treatment For Older Adults Tool on Depression: Assessment and Treatment For Older Adults Based on: National Guidelines for Seniors Mental Health: the Assessment and Treatment of Depression Available on line: www.ccsmh.ca www.nicenet.ca

More information

Bipolar Disorder in Youth

Bipolar Disorder in Youth Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset

More information

Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant

Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant Rhode Island

More information

UNC CFAR Social and Behavioral Science Research Core SABI Database

UNC CFAR Social and Behavioral Science Research Core SABI Database INSTRUMENT TITLE: Hamilton Depression Rating Scale (HDRS) SOURCE ARTICLE: Hamilton, M. (1960). A Rating Scale for Depression. J Neurol Neurosurg Psychiatry, 23: 56-62. RESPONSE OPTIONS: The variables are

More information

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust

PSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions

More information

Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com

Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic

More information

Restless Legs Syndrome (RLS) is a common yet

Restless Legs Syndrome (RLS) is a common yet Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community Hochang B. Lee, M.D. Wayne A. Hening, M.D, Ph.D. Richard P. Allen, Ph.D. Amanda E. Kalaydjian,

More information

Geodon for anxiety and depression

Geodon for anxiety and depression When drugs like carbamazepine or cisapride are taken with Geodon, drug interactions can potentially occur. This emedtv page lists other drugs that may lead to Geodon. 8-2-2017 Find a comprehensive guide

More information

Resubmission. Scottish Medicines Consortium

Resubmission. Scottish Medicines Consortium Scottish Medicines Consortium Resubmission aripiprazole 5mg, 10mg, 15mg, 0mg tablets; 10mg, 15mg orodispersible tablets; 1mg/mL oral solution (Abilify ) No. (498/08) Bristol-Myers Squibb Pharmaceuticals

More information

Early Psychosis Symptoms

Early Psychosis Symptoms ORIGINAL ARTICLE Early Psychosis Symptoms Haider A. Naqvi 1, Sajjad Hussain 1, Muhammad Islam 2 and Shafqat Huma 1 ABSTRACT Objective: To determine the prodromal symptoms of schizophrenia in the pathways

More information